Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Septic Shock
Interventions
DRUG

Iloprost

Continuously infusion for 72 hours. treatment dose 1 ng/kg/min

DRUG

Isotonic saline

Continuously infusion for 72 hours.

Trial Locations (6)

Unknown

Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen

Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen

Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev

Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød

Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre

Region Sealand University Hospital, Køge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Innovation Fund Denmark

INDIV

collaborator

Independent Research Fund Denmark

INDUSTRY

lead

Jakob Stensballe, MD, PhD

OTHER